StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
25
This year
1
Publishing Date
2024 - 01 - 09
1
2023 - 07 - 27
2
2023 - 06 - 09
2
2023 - 04 - 17
1
2023 - 02 - 27
1
2022 - 10 - 27
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 08 - 23
1
2022 - 08 - 22
2
2022 - 07 - 29
1
2022 - 07 - 26
1
2022 - 07 - 18
1
2022 - 06 - 27
1
2022 - 06 - 14
1
2022 - 05 - 23
1
2022 - 05 - 18
1
2022 - 02 - 07
1
2021 - 09 - 17
1
2021 - 06 - 25
1
2021 - 05 - 14
1
2021 - 04 - 16
1
Sector
Communications
2
Electronic technology
2
Energy minerals
2
Finance
2
Health technology
25
Industrial services
2
Manufacturing
1
N/a
2
Producer manufacturing
1
Technology services
1
Utilities
1
Tags
Abbvie
2
Active
3
Advanced
1
America
1
Antibiotics
1
Application
1
Approval
5
Approved
1
Association
1
Atopic dermatitis
1
Authorization
1
Biotech-beach
1
Breast
1
Cancer
2
Chmp
3
Covid
1
Dermatitis
1
Diagnostics
1
Disease
3
Ema
1
Europe
1
Financial report
1
Financial results
1
Growth
9
Implant
1
Iot
1
Leukemia
2
Living
1
Lymphomas
1
Market
11
Meeting
1
Migraine
1
N/a
23
Parkinson's
1
Produodopa
1
Program
1
Regulatory
1
Report
2
Research
3
Results
1
Rinvoq
5
Set
1
Show
1
Therapeutics
3
Therapy
1
Treatment
8
Ulcerative colitis
2
Venclyxto
1
Entities
Abb ltd
1
Abbott laboratories
2
Abbvie inc.
25
Acadia pharmaceuticals inc.
1
Aerie pharmaceuticals, inc.
1
Alcon inc.
1
Amgen inc.
4
Anika therapeutics inc.
1
Astrazeneca plc
3
At&t inc.
2
Bank of montreal
1
Bausch health companies inc.
1
Bp plc
1
Broadcom inc.
1
Canadian imperial bank of commerce
2
Canadian natural resources limited
1
Canon inc
1
Enbridge inc
2
Establishment labs holdings inc.
1
Genmab a/s
1
Glaxosmithkline plc
4
Honeywell international inc.
1
Innate pharma sa
1
Jazz pharmaceuticals plc
1
Johnson & johnson
2
Koninklijke philips nv
1
Mallinckrodt plc
1
Microsoft corporation
1
Novartis ag
5
Pfizer, inc.
1
Puma biotechnology inc
1
Royal bank of canada
1
Sanofi
4
Sun life financial inc.
2
Telus corporation
1
Teva pharmaceutical industries ltd
4
Transalta corporation
1
Viatris inc.
4
Symbols
AAPL
25
ABB
32
ABBV
25
ABLZF
20
ABT
32
ACN
26
ADBE
21
ALPMF
21
ALPMY
21
ALSMY
41
ALV
19
AOMFF
41
ARVL
119
ASX
27
AVGO
30
BLK
36
BNPQF
208
BNPQY
208
BORR
21
BR
21
CLVT
37
CMCL
54
CYAD
20
EGY
25
EQNR
77
ERIC
56
ESLT
49
FLNG
39
FNCTF
95
GOOG
37
GOOGL
37
HON
40
IDBA
23
IPHA
22
IPHYF
21
JCI
19
JNJ
69
KBCSF
27
KBCSY
27
MDT
27
MS
57
NJDCY
25
NOKBF
20
NVO
36
NVS
39
NVSEF
34
PPRUF
28
PPRUY
28
RYLPF
28
SAP
43
SAPGF
41
SEKEF
20
SEKEY
20
SNY
149
SNYNF
120
STLA
28
STOHF
53
TMO
25
VEON
28
VRNA
30
Exchanges
Nasdaq
15
Nyse
25
Crawled Date
2024 - 01 - 09
1
2023 - 07 - 27
2
2023 - 06 - 09
2
2023 - 04 - 17
1
2023 - 02 - 27
1
2022 - 10 - 27
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 08 - 23
1
2022 - 08 - 22
2
2022 - 07 - 29
1
2022 - 07 - 26
1
2022 - 07 - 18
1
2022 - 06 - 27
1
2022 - 06 - 14
1
2022 - 05 - 23
1
2022 - 05 - 18
1
2022 - 02 - 07
1
2021 - 09 - 17
1
2021 - 06 - 25
1
2021 - 05 - 14
1
2021 - 04 - 16
1
Crawled Time
00:00
41
00:20
6
01:00
32
01:10
1
02:00
23
03:00
24
04:00
18
04:20
7
05:00
12
06:00
20
07:00
25
08:00
24
08:20
1
09:00
23
10:00
16
10:10
1
10:51
1
11:00
42
12:00
58
12:15
10
12:20
15
12:30
6
12:34
1
13:00
59
13:07
3
13:13
1
13:15
10
13:17
1
13:20
12
13:27
1
13:30
17
13:50
1
14:00
52
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
10
14:30
12
15:00
50
15:11
1
15:15
7
15:20
10
15:30
16
15:49
1
16:00
49
16:20
7
17:00
38
17:37
1
17:43
1
18:00
39
18:04
1
18:31
2
19:00
32
20:00
49
20:20
7
21:00
27
22:00
37
23:00
45
Source
www.biospace.com
2
www.globenewswire.com
3
www.prnewswire.com
20
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
ABBV
crawled time :
07:00
save search
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
Published:
2024-01-09
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.5%
|
O:
-0.56%
H:
1.26%
C:
0.55%
produodopa
disease
abbvie
parkinson's
advanced
living
Industrial Automation Market outlooks 2027|Market size of the historic period(2017 to 2021), Market size of the forecast period (2023-2027), Growth rate | Technavio
Published:
2023-07-27
(Crawled : 07:00)
- prnewswire.com
ABBNY
|
News
|
$48.37
4.05%
180K
|
n/a
|
22.34%
|
O:
2.13%
H:
0.04%
C:
-1.67%
ABLZF
|
News
|
$48.065
-32.74%
4.7K
|
Producer Manufacturing
|
22.06%
|
O:
0.58%
H:
0.0%
C:
-0.46%
HON
|
News
M
|
$194.27
1.67%
1.64%
3.6M
|
Producer Manufacturing
|
-6.72%
|
O:
-2.18%
H:
0.2%
C:
-3.58%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.64%
|
O:
2.13%
H:
4.77%
C:
3.02%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
14.34%
|
O:
-0.31%
H:
1.71%
C:
0.67%
growth
market
Oil Refining Market all set to rise at growth rate of 1.42% CAGR | Valuation at $121.92 billion between 2022-2027
Published:
2023-07-27
(Crawled : 07:00)
- prnewswire.com
BPAQF
|
$6.45
7.53%
5.1K
|
Energy Minerals
|
6.23%
|
O:
6.73%
H:
0.95%
C:
-5.36%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.64%
|
O:
2.13%
H:
4.77%
C:
3.02%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
14.34%
|
O:
-0.31%
H:
1.71%
C:
0.67%
set
growth
market
AbbVie's VENCLYXTO®/VENCLEXTA® (venetoclax) Continues to Show Sustained Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) Patients
Published:
2023-06-09
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.9%
|
O:
-0.06%
H:
1.18%
C:
0.45%
venclyxto
leukemia
show
Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023
Published:
2023-06-09
(Crawled : 07:00)
- globenewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-27.34%
|
O:
1.67%
H:
0.0%
C:
-3.3%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.9%
|
O:
-0.06%
H:
1.18%
C:
0.45%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-26.13%
|
O:
-0.44%
H:
0.18%
C:
-0.44%
association
lymphomas
meeting
program
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease
Published:
2023-04-17
(Crawled : 07:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.98%
|
O:
0.2%
H:
0.17%
C:
-0.46%
rinvoq
disease
abbvie
active
approval
treatment
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published:
2023-02-27
(Crawled : 07:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-37.72%
|
O:
-0.74%
H:
0.7%
C:
-1.59%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.21%
|
O:
0.64%
H:
0.01%
C:
-0.72%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
8.97%
|
O:
0.36%
H:
0.97%
C:
0.67%
treatment
research
market
Breast Cancer Therapeutics Market Size to Grow by USD 13.85 Bn, Targeted Therapy to be Largest Revenue-generating Product Segment - Technavio
Published:
2022-10-27
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
26.45%
|
O:
0.03%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
18.98%
|
O:
1.47%
H:
0.21%
C:
-0.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
45.48%
|
O:
1.09%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
12.84%
|
O:
0.1%
H:
0.85%
C:
-1.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
18.53%
|
O:
0.06%
H:
0.44%
C:
-0.15%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
21.6%
|
O:
-0.12%
H:
0.47%
C:
0.21%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.11%
|
O:
0.82%
H:
0.15%
C:
-0.17%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
11.19%
|
O:
0.34%
H:
0.0%
C:
0.0%
PBYI
|
$5.01
0.4%
0.4%
290K
|
Health Technology
|
119.74%
|
O:
1.32%
H:
0.43%
C:
-3.46%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
18.27%
|
O:
-0.48%
H:
0.56%
C:
-0.12%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
0.85%
|
O:
0.5%
H:
0.49%
C:
-0.29%
breast
therapeutics
therapy
cancer
market
Beta-Lactam And Beta-Lactamase Inhibitors Market to grow by USD 9.04 Bn, Pharmaceutical Market to be Parent Market - Technavio
Published:
2022-10-17
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
32.72%
|
O:
0.0%
H:
0.0%
C:
-3.61%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
14.71%
|
O:
0.67%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
17.8%
|
O:
1.05%
H:
0.62%
C:
-0.41%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
24.86%
|
O:
2.36%
H:
0.23%
C:
-0.1%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
29.44%
|
O:
2.15%
H:
0.67%
C:
-0.22%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
16.42%
|
O:
-0.2%
H:
1.6%
C:
1.23%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
6.31%
|
O:
1.2%
H:
1.79%
C:
1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
15.82%
|
O:
0.51%
H:
0.95%
C:
0.65%
market
Hyaluronic Acid Raw Material Market Size to Grow by USD 2.87 billion, Need For Safe and Stable Drugs that Require Minimal Monitoring to Boost Market Growth - Technavio
Published:
2022-09-26
(Crawled : 07:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
26.36%
|
O:
5.77%
H:
0.0%
C:
-2.27%
ALC
|
$79.55
1.38%
-0.25%
1.1M
|
Health Technology
|
32.54%
|
O:
-4.07%
H:
2.4%
C:
1.72%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
16.32%
|
O:
-0.69%
H:
0.51%
C:
-0.61%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
20.64%
|
O:
-2.29%
H:
0.35%
C:
-0.67%
ANIK
|
$25.84
1.61%
1.59%
49K
|
Health Technology
|
10.1%
|
O:
0.0%
H:
1.28%
C:
-0.85%
growth
market
Obsessive-Compulsive Disorder Drugs Market, Rising Prevalence Of OCD to Boost Market Growth - Technavio Research Reports
Published:
2022-08-23
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.72%
|
O:
-1.69%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
8.7%
|
O:
-1.35%
H:
1.18%
C:
-0.59%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
11.81%
|
O:
-0.91%
H:
0.1%
C:
-0.17%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
16.74%
|
O:
-0.88%
H:
0.3%
C:
-0.06%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
18.58%
|
O:
-0.49%
H:
0.86%
C:
-0.45%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-30.15%
|
O:
-0.02%
H:
0.79%
C:
-0.36%
research
growth
market
Hairy Cell Leukemia Therapeutics Market Size to Grow by USD 177.85 million, Majority of Growth to Originate from North America - Technavio
Published:
2022-08-22
(Crawled : 07:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.85%
|
O:
2.39%
H:
1.09%
C:
1.09%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
6.43%
|
O:
-0.66%
H:
0.1%
C:
-1.43%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.31%
|
O:
0.08%
H:
0.49%
C:
-1.15%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.05%
|
O:
0.49%
H:
1.11%
C:
-0.39%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
7.2%
|
O:
-0.35%
H:
0.5%
C:
-1.23%
america
leukemia
therapeutics
growth
market
Head And Neck Cancer Diagnostics Market Size to Grow by USD 4.22 billion, Increasing Incidences of Head and Neck Cancers to Drive Growth - Technavio
Published:
2022-08-22
(Crawled : 07:00)
- prnewswire.com
RYLPF
|
News
|
$20.515
3.85%
7K
|
Health Technology
|
9.05%
|
O:
-3.94%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.31%
|
O:
0.08%
H:
0.49%
C:
-1.15%
diagnostics
cancer
growth
market
RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis
Published:
2022-07-29
(Crawled : 07:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.86%
|
O:
-4.04%
H:
0.0%
C:
0.0%
rinvoq
treatment
active
approved
European Commission Approves RINVOQ® (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis
Published:
2022-07-26
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.87%
|
O:
1.61%
H:
0.0%
C:
0.0%
rinvoq
treatment
ulcerative colitis
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine
Published:
2022-07-18
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.63%
|
O:
1.42%
H:
0.0%
C:
0.0%
treatment
ema
application
migraine
authorization
CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis
Published:
2022-06-27
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
10.4%
|
O:
1.55%
H:
0.0%
C:
0.0%
rinvoq
treatment
active
chmp
approval
Breast Implant Market Forecast Report 2021: USD 437.17 Million Market Growth Opportunity by 2025| Technavio
Published:
2022-06-14
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
18.11%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
ESTA
|
$47.425
-9.79%
-10.85%
430K
|
Health Technology
|
-14.81%
|
O:
-1.29%
H:
0.42%
C:
-0.24%
report
implant
growth
market
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
Published:
2022-05-23
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.16%
|
O:
-0.51%
H:
0.0%
C:
0.0%
rinvoq
treatment
chmp
approval
ulcerative colitis
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published:
2022-05-18
(Crawled : 07:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
7.08%
|
O:
-0.31%
H:
0.53%
C:
-0.19%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-10.81%
|
O:
-0.43%
H:
0.0%
C:
0.0%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-21.36%
|
O:
-0.72%
H:
1.09%
C:
-9.3%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
7.33%
|
O:
-0.17%
H:
0.59%
C:
-1.52%
ACAD
|
$16.82
-1.47%
-1.49%
3.5M
|
Health Technology
|
-2.1%
|
O:
-3.61%
H:
1.39%
C:
-3.14%
europe
disease
growth
market
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.